---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-000087"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T00:58:42.663160+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lexaria shareholders re-elect all directors; McKechnie gets 54% support, Baxter 62%

## Summary
- Annual meeting on Jan 14, 2025: 9,761,279 shares (55.93% of outstanding) represented.
- Directors elected: Bunka 89%, Docherty 98%, Baxter 62%, McKechnie 54%, Reese 90%, Christopher 98%, Bhullar 98%.
- Say-on-pay frequency approved every three years with 66% of votes cast; advisory compensation passed at 97%.
- Warrant exercise proposal approved by 70% of votes cast; auditor Malone Bailey LLP ratified with 98%.

## SEC filing metadata
- accession: 0001640334-25-000087
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033425000087/0001640334-25-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033425000087/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-000087
- JSON: https://secwatch.observer/filing/0001640334-25-000087.json
- Plain text: https://secwatch.observer/filing/0001640334-25-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.